Home › Targets › NLRP3

NLRP3 (3 companies · 4 programs)

Companies with an active program directed at NLRP3.

BioAge Labs, Inc. BIOA

BGE-102 — Atherosclerotic Cardiovascular Disease Phase 2
BGE-102 — Diabetic Macular Edema Phase 2

AC Immune SA ACIU

ACI-19764 Phase 1

Monte Rosa Therapeutics, Inc. GLUE

MRT-8102 — Atherosclerotic Cardiovascular Disease Phase 1